Immunotherapy plus an investigational cancer drug improves anti-tumor effects

An investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific kind of cancer cell, a research team at Duke and Harvard have found.

Leave A Comment

Your email address will not be published. Required fields are marked *